Skip to main content

ONCASPAR pegaspargase 3750 units/5 mL injection solution vial, Shire Australia Pty Ltd, CON-223

Product name
ONCASPAR pegaspargase 3750 units/5 mL injection solution vial
Sponsor name
Shire Australia Pty Ltd
ARTG
279831
Consent start
Consent no.
CON-223
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91-Standard for labels of prescription and related medicines
Non-compliance with standard
The labels do not include the name and address of the current sponsor or supplier of the goods.
Conditions imposed
    The labels to which this consent applies are those previously approved for the outgoing sponsor Baxalta and arrangements are in place for the prompt referral of any queries or complaints concerning the products to Shire.  
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site